Available online 8 February 2024

The classification, synthesis, and function of non-coding RNA are introduced.

The oncogenes and tumor suppressor genes of three types of non-coding RNA (circRNA, lncRNA, and miRNA) have been summarized.

The review covers the clinical application of non-coding RNA as a therapeutic target for cancer treatment.

Cancer genomics has led to the discovery of numerous oncogenes and tumor suppressor genes that play critical roles in cancer development and progression. Oncogenes promote cell growth and proliferation, whereas tumor suppressor genes inhibit cell growth and division. The dysregulation of these genes can lead to the development of cancer. Recent studies have focused on non-coding RNAs (ncRNAs), including circular RNA (circRNA), long non-coding RNA (lncRNA), and microRNA (miRNA), as therapeutic targets for cancer. In this article, we discuss the oncogenes and tumor suppressor genes of ncRNAs associated with different types of cancer and their potential as therapeutic targets. Here, we highlight the mechanisms of action of these genes and their clinical applications in cancer treatment. Understanding the molecular mechanisms underlying cancer development and identifying specific therapeutic targets are essential steps towards the development of effective cancer treatments.

Non-coding RNA

therapeutic targets

cancer

clinical application

© 2024 The Author(s). Published by Elsevier B.V. on behalf of Xi’an Jiaotong University.